Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting


WESTLAKE VILLAGE, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present two posters at the 2025 American Academy of Dermatology (AAD) annual meeting which will take place in Orlando, FL, from March 7 – 11, 2025.

Go here to see the original:
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting

Related Posts